DIANA CHAVEZ: Open Payments
NPI 1982154175 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 50 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $261 |
| Exact Sciences Corporation | 7 | $146 |
| GlaxoSmithKline, LLC. | 5 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Lilly USA, LLC | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 5 | $74 |
| PFIZER INC. | 3 | $61 |
| Astellas Pharma US Inc | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Phadia US Inc. | 1 | $26 |
Products named: Ozempic, TRELEGY ELLIPTA, JARDIANCE, Cologuard Collection Kit, VOQUEZNA, The Cologuard Plus Collection Kit, Veozah, MOUNJARO.
Industry payments across TX — which companies pay providers there.
